-transparent.png){kind=logo}
Fourteen patients with membranoproliferative glomerulonephritis as their original kidney disease received 16 renal allografts. All 14 patients are alive, 11 currently have functioning allografts, and one graft was lost to recurrence of membranoproliferative glomerulonephritis. Originally depressed serum complement (C3) concentrations returned to normal soon after transplantation in those patients with no clinical evidence of recurrence. Two patients with type II membranoproliferative glomerulonephritis had recurrence of disease. Nephritic factor (C3NeF) was high in both these patients before they received their transplants and was absent soon thereafter. However, abnormally high levels were again detected in their course. The one recurrence of type I membranoproliferative glomerulonephritis was associated with depressed C3, Clq, C4 and factor B but without C3NeF activity. Despite warnings of "high risks/ and "high mortality" associated with renal transplants in patients with membranoproliferative glomerulonephritis, we, because of these results and a review of the literature, continue to recommend renal transplants from both living related (LRD) and cadaver (CAD) donors in otherwise suitable patients who have renal failure due to membranoproliferative glomerulonephritis.
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
October 2008,
Pediatric nephrology (Berlin, Germany),
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
November 1979,
Archives francaises de pediatrie,
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
January 2004,
Clinical nephrology,
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
January 1987,
Nephron,
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
April 1989,
Clinical and experimental immunology,
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
February 2000,
Australian and New Zealand journal of medicine,
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
February 1994,
Clinical and experimental immunology,
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
June 2001,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
January 1976,
The American journal of medicine,
J J Curtis, and
R J Wyatt, and
D Bhathena, and
B A Lucas, and
N H Holland, and
R G Luke
January 1992,
Nephron,
